BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2003
View Archived Issues
Novel series of HIV protease inhibitors described in recent patent
Read More
Two series of IgE antibody production inhibitors identified by Kowa scientists
Read More
Tularik presents novel modulators of UPC3 with utility in obesity and diabetes
Read More
Spanish team presents novel COX-2 inhibitors in recent patent
Read More
Label for Botox widened in Europe
Read More
Xenova reports progress in 2002
Read More
CV Therapeutics presents novel adenosine A2B antagonists
Read More
Ube scientists identify novel series of leukotriene receptor antagonists
Read More
Novel alpha2- and/or alpha3-selective GABA-A receptor modulators covered by Merck patent
Read More
New PAI-1 inhibitors in early development at Tanabe Seiyaku
Read More
Organix and Virginia Commonwealth U. describe novel CB1 modulators
Read More
Eisai establishes neuroscience drug discovery research program at Kyoto University
Read More
MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies
Read More
Manhattan Pharmaceuticals and Atlantic Technology Ventures complete merger
Read More
Metvix PDT recommended for approval in Australia
Read More
Organon and Ligand to copromote Avinza in U.S.
Read More
EMEA accepts bortezomib MAA for review
Read More
Approval sought for once-daily Reminyl
Read More
Nuvelo reveals alfimeprase program progress in 2002
Read More
Dukoral approved in Canada
Read More
Abilify sNDA submitted for long-term treatment of schizophrenia
Read More
Candidacidal alpha-MSH peptide analogues discovered at Zengen
Read More
Orphan medicinal product designation for Corixa's Bexxar product
Read More
Dendreon to acquire Corvas
Read More
New series of GH secretagogues designed by European research team
Read More
Binding kinetics and cardioprotective effects of sabiporide characterized
Read More
Antiangiogenic activity of FYK-1388 demonstrated in vitro and in vivo
Read More